NuView Radiopharmaceuticals, Inc. Secures Exclusive Rights From Thomas Jefferson University for a Tumor-Specific Imaging Agent for the Diagnosis of Breast and Prosta...(of breast tumors Dr. Thakur'steam is loo...),Health

Date:2/6/2008

of breast tumors, Dr. Thakur's team is looking forward to expanding the Jefferson studies in prostate tumor imaging as well as for therapeutic applications. Peter Conti, M.D., NuView Medical Director said, "In addition to its diagnostic potential, binding of a therapeutic isotope to this agent could lead to a novel targeted radiotherapeutic drug to treat breast and prostate tumors. We are looking forward to exploring both opportunities with the Jefferson investigators."

Further studies of testing imaging techniques are also underway with patients at the Moores Cancer Center at University of California, San Diego Medical Center. "If the Jefferson technology works as well as we hope, it will usher in a whole new generation of diagnostic PET tracers for imaging breast and prostate carcinoma using PET-CT or PET-MR in the future. The improved sensitivity and specificity of these new agents should lead to better treatment and improved patient outcome," said William G. Bradley, Jr., MD, PhD, F.A.C.R., and Chair of Radiology at UCSD.

Thomas Jefferson University, an academic health center, was founded as Jefferson Medical College in 1824. Thomas Jefferson University is composed of Jefferson Medical College, Thomas Jefferson University Hospital, the College of Graduate Studies, and the College of Allied Health Sciences and is committed to educating healthcare and research professionals in a variety of disciplines, discovering new knowledge through translational investigations from the laboratory to the bedside and into the community. Today, this academic health center tests and treats 25,000 inpatients and more than 300,000 outpatients every year, and enrolls 2,600 future health care professionals. Thomas Jefferson University Public and private funding of Jefferson research exceeds $64 million annually. Since its founding, Jefferson Medical College has awarded more than 26,000 medical degrees and has more living graduates than any other medical school in the nat
'/>"/>

SOURCE NuView Radiopharmaceuticals, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine news :

1. BDSI secures US commercial partnership for BEMA Fentanyl with Meda AB
2. Simplex Diabetic Supply, Inc. Secures $50 Million in Growth Equity from New Enterprise Associates
3. UI licensee Optherion secures $37 million in financing
4. IPS Secures National Contract to Deliver FOCUS Healthcare Provider Network Access to Pain Management Specialists
5. Piedmont Pharmaceuticals Secures $8.5 Million Investment
6. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
7. Southwest Ambulance Awarded Exclusive, 3-Year Contract Extension in Peoria, Arizona
8. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
9. Pearson VUE Signs Exclusive Contract with Educational Resources, Inc.
10. NEWSWEEK International Editions: Highlights and Exclusives, Oct. 1, 2007 Issue
11. Crdentias National Director of Travel Services Provides an Exclusive Interview on the Growth of Crdentias Travel Nurse Division